Bruker

1. Dependence on the Medical and Life Science Industries: Bruker Corporation has significant exposure to the medical and life science industries, which are both cyclical businesses. A downturn in those industries would have a negative effect on Bruker’s results of operations.

2. Litigation and Regulatory Risks: Bruker could be exposed to litigation and regulatory proceedings related to product liability or other claims, or to environmental- or safety- related liabilities. Any such claim could be potentially costly and time consuming and its outcome could be adverse.

3. Competition: Bruker faces strong competition in all of its businesses, both from internal and external sources. The market for biomarker identification is particularly competitive, and Bruker will need to constantly innovate and invest in order to remain competitive.

4. Technology: Technological developments in the markets in which Bruker does business could quickly render its products obsolete. Companies with more modern technology may be able to gain an edge over Bruker.

5. Global Business: A significant amount of Bruker's business is conducted on a global scale. This exposes the company to economic, regulatory, political, and currency risks.